By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XTL Biopharmaceuticals Ltd. 

Kiryat Weizmann, Science Park, Bldg 3
P.O. Box 370
Rehovot    76100  Israel
Phone: 972-8-932-4444 Fax: 972-8-930-4445


Company News
XTL Biopharma (XTLB)' Lupus Drug hCDR1 Granted Patent For Pharmaceutical Composition & Manufacturing Processes 2/10/2016 6:51:47 AM
XTL Biopharma (XTLB) Joins Corporate Advisory Council Of The Lupus Foundation Of America 1/27/2016 10:01:19 AM
XTL Biopharmaceuticals Ltd. (XTLB) Announces Encouraging Feedback From U.S. FDA On Its Upcoming IND Filing For Lupus Drug Hcdr1 1/25/2016 7:25:41 AM
XTL Biopharmaceuticals Ltd. (XTLB) Advances Formulation Of Its hCDR1 Drug For Clinical Trials In The Treatment Of Lupus Through Use Of Cydex Pharmaceuticals' Captisol 1/13/2016 8:03:48 AM
XTL Biopharmaceuticals Ltd. (XTLB) Submits Protocol To Yeda For Advanced Clinical Trial Of hCDR1 In The Treatment Of Lupus 1/11/2016 8:07:07 AM
XTL Biopharmaceuticals Ltd. (XTLB) Reports Third Quarter 2015 Results and Confirms Intention to Start Lupus Trial In 2016 12/1/2015 7:45:28 AM
XTL Biopharmaceuticals Ltd. (XTLB) Release: Dr. Murray Urowitz, Of The University Of Toronto University Health Network, Provides Overview Of An Analysis Of Data From A Phase II Clinical Study Of Hcdr1 (Edratide) For The Treatment Of Lupus 10/28/2015 12:50:10 PM
XTL Biopharmaceuticals Ltd. (XTLB) To Present At BIO-Europe 2015 In Munich, Germany On November 3rd, 2015 10/26/2015 12:06:43 PM
XTL Biopharmaceuticals Ltd. (XTLB) Announces Agreement With Yeda Research and Development Company Ltd. To Amend License Agreement For Lupus Asset 10/13/2015 7:36:49 AM
XTL Biopharmaceuticals Ltd. (XTLB) To Present At The Rodman & Renshaw 17th Annual Global Investment Conference On September 10th 2015 At The St. Regis Hotel In NYC 9/3/2015 9:55:33 AM